KBW Maintains Chimera Investment Corp(CIM.US) With Hold Rating, Raises Target Price to $16.5
Chimera Investment Analyst Ratings
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Maintains $15 Price Target
UBS Downgrades Chimera Investment to Neutral From Buy, $5 Price Target
UBS Initiates Coverage On Chimera Investment With Neutral Rating, Announces Price Target of $5.5
Chimera Investment Analyst Ratings
Credit Suisse Maintains Neutral on Chimera Investment, Lowers Price Target to $5.5
What 5 Analyst Ratings Have To Say About Chimera Investment
RBC Capital Maintains Outperform on Chimera Investment, Lowers Price Target to $6
RBC Cuts Price Target on Chimera Investment to $6 From $7, Maintains Outperform Rating
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $5.5
Keefe, Bruyette & Woods Adjusts Price Target on Chimera Investment to $6.25 From $7, Maintains Market Perform Rating
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $6.25
Credit Suisse Sticks to Their Hold Rating for Chimera Investment (CIM)